MERT: Magno-EEG Resonant Therapy

MERT targets the alpha EEG activity. This unique alpha brainwave has been found to be highly associated with brain metabolism, cognitive functions and various types of mental disorders. Clinical trials have shown that the direct adjustment of the physical characteristics via MERT has clinical efficacy in many psychiatric illnesses including:

• ADD/ADHD
• Addiction (Substance Abuse)
• Anxiety disorder
• Autism
• Depression
• Schizophrenia

Case Studies

Autistic Brothers
Two brothers have suffered from autism for 19 and 15 years, respectively. The symptoms for the older brother "Jake" were so severe that his brain development was limited to that of a two year old. He had no language skills and could not even stand up without support. Emotionally he was very irritable. He often lost consciousness with epileptic attacks as frequently as ten times a day. He also had various types of self mutilation behaviors from repetitive rocking in the chair to scratching himself on the face. No communication with any other individuals.

The younger brother "Jack" was less severe in symptoms. His neurological development was about 5 years old. Although he could use some simple words to communicate with parents and care givers, forming a complete sentence was difficult. He could not pronounce English syllables clearly. He often showed stereotypical behavior, such as repeating a phrase or walking between two spots over and over again for a long time. Emotional expression was improper and irritable. Attention span was shorter than 10 minutes on interested subjects.

Following the first two sessions of treatment with MERT, parents realized some dramatic changes in both boys. The older brother's seizure attack reduced significantly with much relaxed muscle tone, reduction in irritation, and better sleep. The younger boy had much better emotional response and extended attention span. Following a year and half rTMS treatment, both boys have had great improvement in their symptoms. For Jake, seizures and self mutilation behaviors have all disappeared. Stereotypical behaviors are also significantly reduced. Muscle tone and incontinent for the severe case are greatly improved. For Jack, the verbal skill and attention span have been so improved that has allowed him to attend school studies now.

Major Depression
"Mr. G" was a successful construction company owner who had a long history of major depressive illness. Because of his uncontrollable depression, he had lost his family and his business. He was suicidal when he sought MERT treatment for his depression. He viewed this as his last hope for relief from his symptoms and promised to give the facility everything he had if the treatment was successful.

After a series of MERT treatments, Mr. G responded positively to the therapy. A week later, he bid and won a $6.5 million contract. Of course, the hospital did not take his financial offer, but Mr. G has become an active promoter for this novel and effective treatment ever since.

Alcoholism and Major Anxiety
"C. B." was a successful business man with dual diagnosis of alcoholism and major anxiety. By the time he sought Dr. Jin's help for his mental disorder, he had already lost his business, family, and house. The main concern for C. B. was that he couldn’t concentrate on his business and had no motivation to plan for the future. He felt that excessive consumption of alcohol was the only way he could calm himself down.

After four sessions of MERT therapy, C. B. felt totally different and had significant improvement in clinical symptoms and attention. He has now paid off years of personal and business debt, purchased a home and restarted his business. In addition to his financial and business focus, he has been able to sleep regularly and has an increased sexual drive. When asked how he felt about the treatment, C. B. described it as a "window cleaning for the mind that enabled him to see everything clearly."

Clinical Studies

The following clinical studies for rTMS (repetitive transcranial magnetic stimulation) highlight the research used as a basis for Brookside Institute’s exclusive protocol Magno-EEG Resonant Therapy (MERT). MERT is an advanced form of rTMS that uses an electroencephalogram (EEG) or brainwave analysis to identify the precise intensity, stimulus frequency, location, duration and maintenance plan to bring the brainwaves back into normal patterns.

Depression
In a six-week double blind study of 50 patients suffering from treatment resistant-depression, a significant number met response (44%) or remission (36%). Sequentially applying both high-frequency left-side rTMS and low-frequency rTMS to the right prefrontal cortex, has substantial treatment efficacy in patients with treatment-resistant major depression. The treatment response accumulates to a clinically meaningful level over 4 to 6 weeks of active treatment.

Schizophrenia
Auditory hallucinations are a common and disabling problem for many patients with schizophrenia and often fail to respond to optimal antipsychotic therapy. Repetitive transcranial magnetic stimulation (rTMS) has recently been tested in clinical trials as an alternative treatment option for these patients. In two cases in which rTMS was provided to patients upon relapse of hallucinations following initial successful rTMS treatment in a clinical trial, a repeat course of rTMS resulted in a marked improvement in the symptoms experienced by these two patients. rTMS appears to have potential as a longterm treatment for patients with auditory hallucinations.

Addiction
Cocaine dependence is a public health problem affecting 2 million individuals in USA. Craving is a predictor of subsequent cocaine use and is related to changes in brain activity in networks involving the prefrontal cortex. In a recent study, one session of high frequency repetitive transcranial magnetic stimulation (rTMS) was used to reduce craving in cocaine addicted subjects. Six patients underwent two sessions of rTMS over left or right dorsolateral prefrontal cortex (DLPFC). Before, immediately after and 4 h after rTMS craving was measured using visual analogue scales. Right, but not left, DLPFC stimulation significantly reduced craving over time. The reduction was 19%. These results highlight the potential of non-invasive neuromodulation as a therapeutic tool for cocaine addiction.